Oxford Instruments one of the leading manufacturer of high technology tools and systems for industrial and academic research on the global label, has announced and placed it’s shares worth $65 million to acquire two group of companies dealing in nanotechnology market.
According to current market analysis we are amazed watching at Oxford status where it is booking a huge profit at it’s shares out and gave 24% jump in full year revenue from £212 million to £262 million (rise in pre-tax profit from £18m to £27m, the company first spin-out company for Oxford University, embarked on the placing which raised £39m on the same day.
It’s shares rose 18 and a half percent to 800 percent as investor reacted at the recent moves from the company officials regarding their business expansion in the nanotechnology market.
According to chief executive Oxford Instruments, Jonathan Flint, those two companies are Frankfurt and Omniprobe and he also announced that Frankfurt – based Omnicron is worth $145 million and Dallas – based Omniprobe is worth $19 million.
No doubt after this collision Oxford Instrument will book huge profit in their current share market holdings and also another business expansion in the market of nanotechnology already covered by Frankfurt and Omniprobe as they were well known established player of their sector.